Christopher Gallen

Christopher Gallen

Presidente en
Treos Bio Ltd.
.
74 años
Health Technology
Commercial Services
Consumer Services

Perfil

Christopher C.
Gallen
is Chairman at Treos Bio Ltd. since 2026.
Former positions include President & Chief Executive Officer at Neuromed Pharmaceuticals, Inc. in 2010 and at Neuromed Pharmaceuticals Ltd. from 2004 to 2010; Senior Director-Medical & Scientific Services at Quintiles International Clinical Research Corp.
in 1995; Vice President-Research & Development at CombinatoRx, Inc. in 2010; President-Clinical Research Organization Division at Premier Research Worldwide in 1998; Chief of Operations & Clinical Research at Wyeth Research from 2002 to 2011; Vice President-Clinical Research at Pharmacia, Inc.; and Executive Vice President-Research & Development at Zalicus, Inc. from 2010 to 2012.
Education includes a doctorate from Emory University and an undergraduate degree from the University of Florida.

Cargos activos de Christopher Gallen

EmpresasCargoInicio
Presidente 28/05/2026

Antiguos cargos conocidos de Christopher Gallen.

EmpresasCargoFin
Director Técnico/Científico/I+D 01/03/2012
Presidente 07/01/2010
Presidente 27/01/2010
Presidente 27/01/2010
Corporate Officer/Principal 01/12/1998
Ver el detalle de la experiencia de Christopher Gallen.

Formación de Christopher Gallen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

28

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Pharmacia, Inc.

Health Technology

Quintiles International Clinical Research Corp.

Commercial Services

  1. Bolsa de valores
  2. Insiders
  3. Christopher Gallen